Eton Pharmaceuticals, Inc. (NASDAQ:ETON) showed up in the 13F filings of 115 institutional investors as of March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 31 Mar, 2026 | 2,860,000 | -2,860,000 | -50.00% | $70,584,800.00 |
| EcoR1 Capital, LLC | 31 Mar, 2026 | 2,171,938 | 141,394 | 6.96% | $53,603,430.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 1,717,286 | -21,621 | -1.24% | $42,382,617.00 |
| Nantahala Capital Management, LLC | 31 Mar, 2026 | 1,175,951 | 0 | 0.00% | $29,022,471.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 994,089 | 994,089 | 0.00% | $24,534,117.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 577,666 | 12,615 | 2.23% | $14,260,695.00 |
| State Street Corp | 31 Mar, 2026 | 530,215 | 28,290 | 5.64% | $13,085,706.00 |
| National Philanthropic Trust | 31 Mar, 2026 | 492,112 | 0 | 0.00% | $12,145,324.00 |
| Morgan Stanley | 31 Mar, 2026 | 477,957 | -15,957 | -3.23% | $11,795,980.00 |
| Westside Investment Management, Inc. | 31 Mar, 2026 | 467,915 | -3,025 | -0.64% | $11,548,309.00 |
| OBERWEIS ASSET MANAGEMENT INC/ | 31 Mar, 2026 | 439,300 | 8,000 | 1.85% | $10,841,924.00 |
| THOMPSON SIEGEL & WALMSLEY LLC | 31 Mar, 2026 | 406,089 | -2,452 | -0.60% | $10,022.00 |
| Pillsbury Lake Capital LLC | 31 Mar, 2026 | 364,954 | 364,954 | 0.00% | $9,007,065.00 |
| CANNELL CAPITAL LLC | 31 Mar, 2026 | 341,985 | 125,068 | 57.66% | $8,440,190.00 |
| BNP PARIBAS FINANCIAL MARKETS | 31 Mar, 2026 | 302,108 | 24,650 | 8.88% | $7,456,025.00 |
| Northern Trust Corp | 31 Mar, 2026 | 237,832 | 5,983 | 2.58% | $5,869,693.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 217,446 | -175,080 | -44.60% | $5,366,567.00 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 188,802 | 143,477 | 316.55% | $4,659,633.00 |
| Aristides Capital LLC | 31 Mar, 2026 | 186,041 | -136,831 | -42.38% | $4,591,492.00 |
| Panoramic Capital, LLC | 31 Mar, 2026 | 185,000 | 185,000 | 0.00% | $4,565,800.00 |